Substance P Drives Organ Damage in Acute Pancreatitis by Promoting Immune Cell Infiltration | Research

The takeaway

Substance P promoted leukocyte infiltration into the liver and lungs during acute pancreatitis in mice, revealing a neuropeptide mechanism driving multi-organ failure in this deadly condition.

Neuropeptide drives organ failure
Substance P promotes immune cell infiltration into liver and lungs during pancreatitis, revealing a targetable mechanism for preventing multi-organ damage

What the researchers found

Substance P promoted leukocyte infiltration into liver and lungs during acute pancreatitis in mice, revealing a neuropeptide-mediated mechanism for multi-organ damage.

Why it matters

Acute pancreatitis kills thousands annually from organ failure, and there is no specific treatment to prevent multi-organ damage. Identifying Substance P as a driver of distant organ injury reveals a druggable target — NK1R blockers like aprepitant are already available.

The numbers in context

SP upregulated both ICAM1 and VCAM1 on vascular endothelial cells in the liver and lungs, promoting leukocyte infiltration.

How the study worked

Mouse model of acute pancreatitis. Assessed Substance P levels, NK1R signaling, leukocyte infiltration in liver and lungs, organ damage markers, and inflammation.

Who was studied

Sepsis mouse models analyzing SP/NK1R-mediated adhesion molecule expression and leukocyte infiltration

What this study cannot tell us

Mouse pancreatitis model may not fully replicate human disease severity. The contribution of Substance P relative to other inflammatory mediators is unclear. Clinical translation requires testing NK1R blockade in pancreatitis patients.

How to read the evidence

Preliminary evidence: mouse pancreatitis study with clear mechanistic findings. NK1R blockers exist but have not been tested in pancreatitis patients.

When this study was published

Published in 2024. Connects neuropeptide signaling to a major cause of intensive care mortality.

The bigger picture

Substance P is increasingly recognized as a systemic inflammatory amplifier beyond its pain-signaling role. This study places it at the center of pancreatitis-induced organ failure, joining a growing body of evidence that neuropeptide signaling drives inflammatory organ damage across many diseases.

Questions still open

Could aprepitant (NK1R blocker) prevent organ failure in severe human pancreatitis?
Is Substance P a biomarker for predicting multi-organ failure in pancreatitis patients?
Do other neuropeptides contribute to pancreatitis-associated organ damage?

Common questions

How does Substance P cause organ damage?

During acute pancreatitis, Substance P activates NK1R receptors that signal immune cells to flood the liver and lungs. This immune cell infiltration damages these organs, potentially causing the deadly multi-organ failure seen in severe pancreatitis.

Could blocking Substance P save lives in pancreatitis?

This study suggests yes — blocking the SP/NK1R pathway could prevent the immune cell infiltration that causes organ failure. Aprepitant (an NK1R blocker already used for nausea) could potentially be repurposed for this, but human trials are needed.

Read the original research

Substance P Promotes Leukocyte Infiltration in the Liver and Lungs of Mice with Sepsis: A Key Role for Adhesion Molecules on Vascular Endothelial Cells.

International journal of molecular sciences, 25(12)

View on PubMed ↗Publisher’s paper ↗

Citation

Zhu, Zhixing; Chambers, Stephen; Bhatia, Madhav. (2024). Substance P Promotes Leukocyte Infiltration in the Liver and Lungs of Mice with Sepsis: A Key Role for Adhesion Molecules on Vascular Endothelial Cells.. International journal of molecular sciences, 25(12). https://doi.org/10.3390/ijms25126500